ir.aspirawh.comAspira Women's Health
ir.aspirawh.com Profile
Ir.aspirawh.com is a subdomain of aspirawh.com, which was created on 2020-04-23,making it 4 years ago.
Discover ir.aspirawh.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.aspirawh.com Information
| HomePage size: 119.917 KB |
| Page Load Time: 0.189721 Seconds |
| Website IP Address: 104.26.14.4 |
ir.aspirawh.com Similar Website
| Women Excelling Chapter | American Business Women's Association |
| Lifeway Women - Lifeway Women provides biblical solutions for churches, small groups and individuals |
| P.E.O. International - Where Women Motivate Women |
| LA Galaxy San Diego Women's WPSL Team |
| Texas Women – Texas Women Make Texas History |
| National Women's Histor Museum Events – A renowned leader in women’s history education, the National |
| Russian Women - Asian Women - Latin Women - Dating Service - Love Me - A Foreign Affair |
| Inc. Women's Summit | Join women entrepreneurs and business leaders for the premier women's business |
| Axia Women's Health | Women Deserve More |
| ‘One Woman’ – The UN Women song | About us: About UN Women | UN Women – Headquarters |
| Aspira One - Launch Manager |
| Women's Health Shop Home | Women's Health Shop |
| Lifestyle - Women Lifestyle Blogs. Women are blogging about lifestyle,diet,health,beauty and shoppin |
| Axia Women's Health | Women Deserve More |
| Axia Women's Health | Women Deserve |
ir.aspirawh.com PopUrls
| Aspira Women's Health https://ir.aspirawh.com/ |
| News https://ir.aspirawh.com/news/ |
| SEC Filings https://ir.aspirawh.com/sec-filings/ |
| Corporate Governance https://ir.aspirawh.com/corporate-governance/ |
| Stock Information https://ir.aspirawh.com/stock-information/ |
| Unsubscribe https://ir.aspirawh.com/unsubscribe/ |
| Events & Presentations https://ir.aspirawh.com/events-presentations/ |
| Leadership https://ir.aspirawh.com/leadership/ |
| VRML https://ir.aspirawh.com/tag/vrml/ |
| Aspira Women’s Health Reports Fourth Quarter and Full Year 2022 ... https://ir.aspirawh.com/press-release/aspira-womens-health-reports-fourth-quarter-and-full-year-2022-financial-results/ |
| Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 ... https://ir.aspirawh.com/press-release/aspira-womens-health-reports-fourth-quarter-and-full-year-2023-financial-results/ |
| Aspira Women’s Health Reports First Quarter 2024 Financial Results https://ir.aspirawh.com/press-release/aspira-womens-health-reports-first-quarter-2024-financial-results/ |
| Aspira Women's Health Announces Transition of its Chief Scientific ... https://ir.aspirawh.com/press-release/aspira-womens-health-announces-transition-of-its-chief-scientific-officer-chief-operating-officer/ |
| Aspira Women’s Health Reports Third Quarter 2023 Financial Results https://ir.aspirawh.com/press-release/aspira-womens-health-reports-third-quarter-2023-financial-results/ |
ir.aspirawh.com Httpheader
| Date: Sun, 12 May 2024 09:38:40 GMT |
| Content-Type: text/html; charset=UTF-8 |
| Transfer-Encoding: chunked |
| Connection: keep-alive |
| Vary: Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie |
| Link: https://ir.aspirawh.com/wp-json/; rel="https://api.w.org/", https://ir.aspirawh.com/wp-json/wp/v2/pages/7427; rel="alternate"; type="application/json", https://ir.aspirawh.com/; rel=shortlink |
| X-Powered-By: WP Engine |
| X-Cacheable: YES:600.000 |
| Cache-Control: max-age=600,public |
| X-Cache: HIT: 18 |
| X-Cache-Group: normal |
| CF-Cache-Status: DYNAMIC |
| Report-To: "endpoints":["url":"https:\\/\\/a.nel.cloudflare.com\\/report\\/v4?s=HKHQI%2FyJZX5pklcHLu5yz4QyZwwRPgJKK1vhVTAT28MpTFccGIFK961xxoNengWMXx9X24XCiP34njavnIWWBItXOv6iCEEX4%2FxaIZAHruGPNKo3x5rh8mI5pPLai80nxeyBNXHXRDAPV5fGAQ%3D%3D"],"group":"cf-nel","max_age":604800 |
| NEL: "success_fraction":0,"report_to":"cf-nel","max_age":604800 |
| Server: cloudflare |
| CF-RAY: 88296fe99ffb7e71-LAX |
ir.aspirawh.com Meta Info
| charset="utf-8"/ |
| content="width=device-width, initial-scale=1" name="viewport"/ |
| content="7ff782a3da79d9bfbc0c0578577352e4" name="p:domain_verify"/ |
| content="5kevtqmxeuusnoypi780zlncpgb82p" name="facebook-domain-verification"/ |
| content="max-image-preview:large" name="robots"/ |
| content="https://ir.aspirawh.com/wp-content/uploads/2020/01/cropped-aspira-favicon-270x270.png" name="msapplication-TileImage"/ |
ir.aspirawh.com Html To Plain Text
Products Find Out More OvaSuite OvaSuite OvaWatch Ova1Plus Contact Us Order a Kit Providers Find Out More For Providers Research and Professional Guidelines Clinical Studies Aspira Synergy Events Contact Aspira Contact Us Order a Kit Patients Find Out More For Patients Learn More About Adnexal Masses Insurance and Billing Find a Provider Contact Aspira Contact Us Pay My Bill Investors Check out our Press Releases Explore For Investors Investor Overview News Events & Presentations Resources SEC Filings Stock Information Corporate Governance Contact Us News AlertsFind Out More About Aspira About Aspira Women’s Health Our History Leadership News Contact Us Careers Licensure & Legal – Aspira Labs Code of Conduct Contact Us Latest News Follow Us: News Events Contact Us Aspira is Transforming Women’s Health with Innovative Solutions Investor Quick Links News Events & Presentations SEC Filings Corporate Presentation Corporate Governance Stock InformationAspira is led by an experienced team of business, medical and scientific professionals with a passion for improving health outcomes for women. Meet our Leadership Team About Our Mission is helping transform women’s health with the discovery, development, and utilization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. Our FDA-cleared products Ova1 ® and Overa ® detect the risk of ovarian malignancy in women with adnexal masses. With over 10 years of experience in ovarian cancer risk assessment, has expertise in cutting-edge research to inform our next generation of products. Our focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection and optimize treatment plans. Learn More View Stock Information Most Recent Press Releases UPDATE — Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15 May 8, 2024 May 08, 2024 08:47 ET AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (Aspira” or the Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that the Company will report its financial results for the three months ended March 31, 2024,… Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15 May 8, 2024 May 08, 2024 08:00 ET AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (Aspira” or the Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that the Company will report its financial results for the three months ended March 31,… View all Press Releases Investor Relations Contact Contact: Torsten Hombeck, Ph.D., SVP and CFO [email protected] Email I accept the Privacy Policy Submit Unsubscribe Contact Us Tel: 844-ASPIRA1 (844-277-4721) Fax: 512-869-4114 12117 Bee Caves Road Building III, Suite 100 Austin, TX 78738 Investors Investor Overview Events & Presentations SEC Filings Corporate Governance Stock InformationAbout Aspira Leadership Licensure & Legal News News Events Follow Us Copyright © 2024 . All Rights Reserved. | Privacy Policy Please note that we use cookies necessary for the functioning of our website, and to optimize the performance. To learn more about our cookies, how we use them and their benefits, please read our Cookie Policy . I...
ir.aspirawh.com Whois
Domain Name: ASPIRAWH.COM Registry Domain ID: 2517906275_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2024-04-24T11:15:37Z Creation Date: 2020-04-23T17:09:18Z Registry Expiry Date: 2025-04-23T17:09:18Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: GAIL.NS.CLOUDFLARE.COM Name Server: JIM.NS.CLOUDFLARE.COM DNSSEC: signedDelegation DNSSEC DS Data: 2371 13 2 9E898A90A5F32D83D6B30102191F65E9769ECD7E25AC9B9058733B5DF7AA16C4 >>> Last update of whois database: 2024-05-17T15:07:28Z <<<